Inositol mammals

About 10-20% of all transmembrane proteins that are targeted to the ER and subsequently enter the secretory pathway are subject to post-translational modification with glycosylphosphatidyl-inositol (GPI). Proteins bearing the GPI anchor are involved in signal transduction, immune response, cancer cell invasion, and metastasis and the pathobiology of trypanosomal parasites. The structure of the GPI anchor has been analyzed for mammals, protozoa, and yeast. The general structure of the glycolipid structure is shown in Scheme 4. 

In mammals, the increased uptake of the osmolyte myo-inositol in response to hyperosmolarity has been described in renal medulla cells, lens epithelia, astrocytes, endothelial cells, and Kupffer cells (Paredes et al., 1992 Nakanishi et al., 1988 Warskulat et al., 1997 Wiese et al., 1996 Zhou et al., 1994). The hyper-osmolarity-induced myo-inositol accumulation inside these cells is the result of both an increase in the Vmax of the SMIT and the increased expression of its gene (Kwon et al., 1992 Nakanishi et al., 1989). Conversely, hypo-osmotic exposure... 

Functional expression of the human inositol synthase cDNA in yeast cells devoid of the INOl gene shows that it can complement inositol auxotrophy and excrete inositol (Ju et al., 2004). When grown in valproate (0.6 mM), these cells show a 35 and 25% decrease in synthase activity and inositol levels, respectively. However, valproate does not directly inhibit synthase activity at this concentration (0.6 mM) implying that this mood stabilizer works probably at the translational or transcriptional levels. Inositol synthase is present in a wide variety of organisms (protozoa, fiingi, plants and mammals) and has been... 

In the budding yeast, inositol polyphosphate synthesis proceeds via what is likely to be one of the earliest incarnations of a PLC-dependent pathway for higher inositol polyphosphate metabolism in eukaryotes. Early biochemical studies in yeast (and plants) failed to identify a calcium-sensitive Ins(l,4,5)P3 3-kinase activity analogous to that found in mammalian cells. Instead, these studies identified C6-hydroxyl phosphorylation of Ins(l,4,5)P3 and formation of Ins(l,4,5,6)P4 as the most likely first anabolic step in the production of higher inositol polyphosphates (22). Additional biochemical studies identified the sequential phosphorylation of Ins(l,4,5,6)P4 to Ins(l,3,4,5,6)P5 followed by Ins(l,2,3,4,5,6)P6 (23). These findings were interpreted as proof of the existence of disparate pathways in yeast and mammals for the metabolism and functionality of Ins(l,4,5)P3. In contrast, the eventual cloning of the yeast Ins(l,4,5)P3 kinase activity found that mammalian and yeast inositol metabolism were more closely related than initially suspected. 

As yeast contains only a single InsPg-kinase (mammals contain three isoforms), much of what we know regarding the functional roles of inositol diphosphates is the result of... 

Phosphatidate is formed by successive acylations of glycerol 3-phosphate by acyl Co A. Flydrolysis of its phosphoryl group followed by acylation yields a triacylglycerol. CDP-diacylglycerol, the activated intermediate in the de novo synthesis of several phospholipids, is formed from phosphatidate and CTP. The activated phosphatidyl unit is then transferred to the hydroxyl group of a polar alcohol, such as inositol, to form a phospholipid such as phosphatidylinositol. In mammals, phosphatidylethanolamine is formed by CDP-ethanolamine and diacylglycerol. Phosphatidylethanolamine is methylated by S-adenosylmethionine to form phosphatidylcholine. In mammals, this phosphoglyceride can also be synthesized by a pathway that utilizes dietary choline. CDP-choline is the activated intermediate in this route. 

I ts mode of action is unknown. The theory of Slade (1945) according to which the y-isomer exerts its action as the antimetabolite of hexahydroxycyclohexane (meso-inositol) of identical steric structure, present in the organism of certain microorganisms and mammals, could not be upheld in the light of recent experimental results. It has been made clear by recent structural investigations that the steric structure of meso-inositol is not identical with that presumed earlier. Its presence in the insect organism is of no importance and, moreover, the effect of BHC cannot be counteracted by the administration of wejo-inositol. 

The muscarinic cholinergic system has quite a different mode of operation in that the receptor is connected to the final action by a chain of events. Thus its response is slower than the nicotinic, where the receptor and ion channel are closely connected. Five distinct muscarinic receptors have been identified in mammals, based on anatomical location, genetic analysis, function, and amino acid sequence. All of them have seven transmembrane domains [166, 167, 168, 169]. The N- terminal domain outside the cell binds acetylcholine or other ligands at a site that includes an aspartate residue, while the C-terminal domain inside the cell is coupled to a so-called G-protein , which is initially bound to guanosine diphosphate (GDP), but exchanges it for guanosine triphosphate (GTP) when activated by its transmitter. The activated G-protein then activates phospholipase C, which hydrolyzes phosphoinositides to release 1,4,5-inositol triphosphate [170]. The final action depends on which type of cell is involved so that in some types ion channels are opened just as with the nicotinic receptor, but in other cases other processes are affected, for example the release of dopamine [171]. Since there are these differences... 

---